In tumor samples from patients with NSCLC treated with ICIs, high CD4+ cell densities in the tumor cores correlated with favorable clinical outcomes, highlighting the clinical utility of our noninvasive PET imaging approach. This evidence concerns the gene CD4 and neoplasm.